A game-changer in the fight against HIV, pre-exposure prophylaxis (PrEP) is a highly effective drug that reduces the risk of acquiring the condition. But as the NHS trials PrEP across England, many at high risk have struggled to get hold of the drug.

The Impact trial was launched in England in October 2017 with an initial 10,000 places at sexual health clinics for people at high risk of contracting HIV.

But there has been great

Read More At Article Source | Article Attribution